Ledger.Open graph →
SEC Form D · filed September 30, 2016

Aura Biosciences, Inc

Offering
$8.0M
Sold
$1.8M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
CAMBRIDGE, MA
Type

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (31)

Art E. Pappas · Cambridge, MADirectorDale E. Pfost, Ph.D · Cambridge, MADirectorMichael E. Wyzga · Cambridge, MAExecElisabet De Los Pinos, Ph.D · Cambridge, MAExec · DirectorRaj E. Parekh, Ph.D · Cambridge, MADirectorAlan E. Walts, Ph.D · Cambridge, MADirectorJoel E. Jean-Mairet, Ph.D · Cambridge, MADirectorPeter E. Wirth · Cambridge, MADirectorLewis E. Geffen · Cambridge, MAExecJose' E. Baselga, Ph.D · Cambridge, MADirectorHenri E. Termeer · Cambridge, MADirectorNigel Morris · CHARLOTTE, NCDirectorMatt Harris · CHARLOTTE, NCDirectorPhillip Chapple · Hamilton, BermudaExecRichard L. Mcquady · Columbus, OHDirectorHarold D. Keller · Columbus, OHDirectorDenise A. Olsen · CHICAGO, ILExec · DirectorDaniel M. Rosenbloom · CHICAGO, ILDirectorDeepak Sindwani · Boston, MAExecJohn P. Lee · Columbus, OHDirectorEric M. Siegal · CHICAGO, ILExec · DirectorRD Legal Capital, LLC · Cresskill, NJDirectorDennis S. Guest · Columbus, OHDirectorThomas T. Loos · Columbus, OHDirectorDaniel M. Slane · COLUMBUS, OHDirectorSusan E. Weaver · Columbus, OHDirectorMario M. Gutierrez · Seattle, WADirectorGrant G. Farwell · Seattle, WADirectorAnthony M. Farwell · Seattle, WAExecMichael A. Bruun · NEW YORK, NYExecHenri E. Termeer · Cambridge, MADirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗